胰岛素抵抗相关因子与妊娠期高血压疾病的关系
被引量:4
摘要
妊娠期高血压疾病(hypertensive disorder complicationpregnancy,HDCP)是妊娠期特有的疾病,国内发病率为9.4%,国外报道为7%-12%,其病因及发病机制复杂多样,可能与遗传免疫因素、胎盘和滋养叶细胞缺血、
出处
《中国妇幼保健》
CAS
北大核心
2011年第6期944-946,共3页
Maternal and Child Health Care of China
参考文献16
-
1Hara K, Horikoshi M, Yamauchi T et al. Measurement of the high - molecular weight form of adiponectin in plasma is useful for the predic tion of insulin resistance and metabolic syndrome [ J] . Diabetes Care 2006, 29 (6): 1357.
-
2Diez JJ, Igjesia P. The role of the novel adipocyte - derived hormone ad- iponeetin in human disease [ J ]. Eur J Endocrinol, 2003, 148 (3) : 293.
-
3Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin [J] . Clin Chem, 2004, 50:1511.
-
4Kajantie E, Hytinantti T. Cord plasma adiponectin : a 20 - fold rise between 24 weeks gestation and term [J] . The Journal of Clinical Endocrinology & Metabolism. 2004, 89 (8) : 4031.
-
5D'Anna R, Baviera G, Corrado F, et al. Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders [J] . Obstet Gynecol, 2005, 106 (2) : 340.
-
6Eero Kajantie, Risto Kaaja. Adiponectin concentrations in maternal serum: elevated in preeclampsis but unrelated to insulin sensitivity [J].Journal of the Society for Gynecologic Investigation, 2005, 12 (6) : 433.
-
7Wang X, Hiroko S, Hiroyuki K et al. Stimulated HSP30 binding to eNOS and activation of PI3 - Akt pathway contribute to globular adiponectin - induced NO production: Vasorelaxation in response to globular adiponectin [ J ] . Biochem Biophys Res Commun, 2005, 332: 200.
-
8Knacksted T, Ishihara N, Matsuo H, et al. Increased apoptosis in the syncytotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation [J]. Am J Ohstet Gynecol, 2002, 186 (1): 158.
-
9Melczer Z, Banhidy F, Csomor S, et al Influence of leptin and the TNF system on insulin resistance in pregnancy and their effect on anthropametric parameters of newborns [ J ] . Acta Obstet Gynecol Scand, 2003, 82 (5):432.
-
10Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes [J] . Nature, 2001, 409 (6818) : 307.
同被引文献50
-
1乐杰.妇产科学[M].北京:人民卫生出版社,2013:104-105.
-
2lnadera H. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems[J ]. Int J Med Sci, 2008, 5(5): 248.
-
3Inadera H. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems[J]. Int J Med Sci, 2008,5(5) :248.
-
4Gupta Y, Kalra B, Singla R, et al. Trends in glyburide comparedwith insulin use for gestational diabetes treatment in the UnitedStates, 2000-201 l[J].Obstet Gynecol,2014,124(3):633-634.
-
5Phithakwatchara N,Titapant V. The effect of pre-pregnancyweight on delivery outcome and birth weight in potential diabeticpatients with normal screening for gestational diabetes mellitus inSiriraj hospital[J].J Med Assoc Thai, 2007,90(2) ; 229-326.
-
6张载宏,高亚飞,杨锐,等.236例妊娠期妇女糖筛查分析[J].中国优生优育,2014,20(3):163-164.
-
7Kevat DA, Sinha AK, McLean AG. Lower treatment targets forgestational diabetes: is lower really better [J]. Med J Aust,2014,201(4):204-207.
-
8Hollander MH, Paarlberg KM, Huisjes AJ. Gestational diabetes : areview of the current literature and guidelines [J].Obstet GynecolSurv,2007,62(1) :125-136.
-
9d,Emden MC. Reassessment of the new diagnostic thresholds forgestational diabetes mellitus: an opportunity for improvement [J].Med J Aust,2014,201(4):209-211.
-
10Sun Y,Yang HX, Sun WJ. Risk factors of pre-eclampsia inChinese pregnant women with abnormal glueosemetabolism[J].IntJ Gynecol 0bstet,2008,99(7):714-717.
引证文献4
-
1杨永碧.血清脂联素在妊娠期高血压疾病中的变化及其与胰岛素抵抗的关系[J].实用临床医药杂志,2014,18(3):124-126. 被引量:4
-
2杨永碧.血清脂联素在妊娠期高血压疾病中的变化及其与胰岛素抵抗的关系[J].华南国防医学杂志,2014,28(4):340-342. 被引量:4
-
3郭红薇,宋麦玲.妊娠合并糖代谢异常对产妇妊娠与新生儿的影响[J].西南国防医药,2016,26(2):165-168. 被引量:11
-
4孙莎,袁克芳,高志敏,武丽蕊,李红霞.妊娠期高血压患者血清脂联素、胰岛素、高敏C反应蛋白的表达水平及其意义[J].医学临床研究,2018,35(4):684-686. 被引量:11
二级引证文献29
-
1谢菲,高歌,张成敏.血清空腹血清胰岛素、Ca2+、脂联素在妊娠期高血压中的表达及临床意义[J].江苏预防医学,2020,31(2):145-147. 被引量:3
-
2张淑芳,于易,田晓蕾,陈梅.妊娠糖尿病患者血清脂联素水平变化及其与炎症因子胰岛素抵抗的关系[J].河北医学,2015,21(2):272-275. 被引量:22
-
3陈颖.妊娠糖尿病患者血清脂多糖、蛋白质核因子-κB、可溶性细胞间黏附分子-1、脂联素水平变化及意义[J].中国临床医生杂志,2016,44(5):88-90. 被引量:3
-
4邵光,胡春玲,吴喜才.妊娠糖尿病患者脂联素水平及其与胰岛素抵抗的相关性分析[J].深圳中西医结合杂志,2016,26(10):3-4.
-
5韩秀英,杜咏梅,付金国.老年原发性高血压患者血清脂联素水平与胰岛素抵抗的相关性研究[J].医学临床研究,2016,33(7):1405-1407. 被引量:7
-
6龚丹.妊娠糖尿病对新生儿高胆红素血症的影响[J].医疗装备,2017,30(15):53-54.
-
7张少迪,王姣,王守俊.妊娠糖耐量异常血糖水平与甲状腺抗体关系[J].河南医学研究,2017,26(16):2912-2914. 被引量:1
-
8肖孝凤,胡爱珍,孙霞.妊娠合并糖代谢异常孕妇围生期血糖控制与妊娠结局关系研究[J].当代医学,2018,24(4):138-139. 被引量:2
-
9刘荣欣,曲首辉,鲍志敏.妊娠期糖代谢异常对新生儿出生结局的影响分析[J].医药论坛杂志,2018,39(5):114-115. 被引量:3
-
10尕项卓玛,简勤勤,秦风雪.孕妇子痫前期并发糖代谢异常对新生儿的影响[J].检验医学与临床,2018,15(12):1830-1832. 被引量:5
-
1魏菲,李慕军.胎盘生长因子在子痫前期中的研究进展[J].中国妇幼保健,2011,26(28):4471-4474. 被引量:1
-
2兰晓娥,洪惠珠.妊娠高血压综合征患者分析与护理对策[J].实用全科医学,2007,5(7):657-658. 被引量:12
-
3张莉,韩素云.宫颈妊娠3例[J].西北国防医学杂志,2004,25(5):344-344.
-
4吴兵,宣柏云.剖宫产子宫瘢痕妊娠的诊治分析[J].浙江临床医学,2005,7(11):1190-1190. 被引量:1
-
5陈静平.剖宫产后子宫瘢痕妊娠的早期诊断及治疗[J].微创医学,2014,9(5):612-615. 被引量:6
-
6黄春燕,王锡梅.妊娠期高血压疾病与其并发症妊娠期肝内胆汁淤积症的关系[J].中国血液流变学杂志,2006,16(4):618-619. 被引量:5
-
7乔福元,刘玉凌.妊娠期高血压疾病的早期预测[J].中国实用妇科与产科杂志,2004,20(10):583-584. 被引量:16
-
8夏冬梅.妊娠期高血压疾病19例临床诊疗[J].中国民族民间医药,2009,18(1):85-86. 被引量:1
-
9陈伟.妊高症30例临床诊治分析[J].中国医疗前沿,2009,4(1):79-79. 被引量:2
-
10姚慕崑.腹腔镜下手术配伍小剂量甲氨蝶呤治疗宫外孕疗效观察[J].现代中西医结合杂志,2006,15(12):1628-1628. 被引量:1